Skip to main content
Log in

Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

In this study, we demonstrate that tumor lysate-loaded dendritic cells can elicit a specific CD8+ cytotoxic T lymphocyte response against autologous tumor cells in patients with malignant glioma. CTL from three of five patients expressed strong cytolytic activity against autologous glioma cells, did not lyse autologous lymphoblasts and were variably cytotoxic against the LAK-sensitive cell line Daudi. Also, DCs pulsed normal brain lysate failed to induce cytolytic activity against autologous glioma cells, suggesting the lack of autoimmune response. Two of five patients CD8+ T cells expressed a modest cytotoxicity against autologous glioma cells. CD8+ T cells isolated during these ineffective primings secreted large amounts of IL-10, less amounts of IFN-γ as detected by ELISA, Type 2 bias in the CD8+ T cell response accounts for the lack of cytotoxic effector function from these patients. Cytotoxicity against autologous glioma cells could be significantly inhibited by anti-HLA class I antibody. These data demonstrate that tumor lysate-loaded DC can be an effective tool in inducing glioma-specific CD8+ CTL able to kill autologous glioma cells in vitro. However, high levels of tumor specific tolerance in some patients may account for a significant barrier to therapeutic vaccination. Moreover, cytotoxic responses were augmented by transfecting DC with the gene for IL-18. For all five patients, CD8+T cells treated with IL18 transfected DC produced Th1 response. These results may have important implications for the treatment of malignant glioma patients with immunotherapy. DCs loaded with total tumor lysate and IL-18 may represent a method for inducing Th1 immunoresponses against the entire repertoire of glioma antigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G Dranoff E Jaffee A Lazenby P Golumbek H Levitsky K Brose V Jackson H Hamada D Pardoll RC Mulligan (1993) ArticleTitleVaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 3539–3543 Occurrence Handle1:CAS:528:DyaK3sXktVKqt78%3D Occurrence Handle8097319

    CAS  PubMed  Google Scholar 

  2. JH Sampson GE Archer DM Ashley HE Fuchs LP Hale G Dranoff DD Bigner (1996) ArticleTitleSubcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the “immunologically privileged” central nervous system Proc Natl Acad Sci USA 93 10399–10404 Occurrence Handle10.1073/pnas.93.19.10399 Occurrence Handle1:CAS:528:DyaK28XlslGku7g%3D Occurrence Handle8816812

    Article  CAS  PubMed  Google Scholar 

  3. JS Yu CJ Wheeler PM Zeltzer H Ying DN Finger PK Lee WH Yong F Incardona RC Thompson MS Riedinger W Zhang RM Prins KL Black (2001) ArticleTitleVaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T cell infiltration Cancer Res 61 842–847 Occurrence Handle1:CAS:528:DC%2BD3MXhsFSrtLs%3D Occurrence Handle11221866

    CAS  PubMed  Google Scholar 

  4. H Aoki M Mizuno A Natsume T Tsugawa K Tsujimura T Takahashi J Yoshida (2001) ArticleTitleDendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor Cancer Immunol Immunother 50 463–468 Occurrence Handle10.1007/s002620100220 Occurrence Handle1:CAS:528:DC%2BD38Xjsl2jtw%3D%3D Occurrence Handle11761440

    Article  CAS  PubMed  Google Scholar 

  5. AB Heimberger LE Crotty GE Archer RE McLendon A Friedman G Dranoff DD Bigner JH Sampson (2000) ArticleTitleBone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma J Neuroimmunol 103 16–25 Occurrence Handle10.1016/S0165-5728(99)00172-1 Occurrence Handle1:CAS:528:DC%2BD3cXltVensg%3D%3D Occurrence Handle10674985

    Article  CAS  PubMed  Google Scholar 

  6. O Insug G Ku HC Ertl M Blaszczyk-Thurin (2002) ArticleTitleA dendritic cell vaccine induces protective immunity to intracranial growth of glioma Anticancer Res 22 613–621 Occurrence Handle1:CAS:528:DC%2BD38XktF2ntLo%3D Occurrence Handle12014629

    CAS  PubMed  Google Scholar 

  7. T Kikuchi Y Akasaki M Irie S Homma T Abe T Ohno (2001) ArticleTitleResults of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunol Immunother 50 337–344 Occurrence Handle10.1007/s002620100205 Occurrence Handle1:STN:280:DC%2BD3MrntVSjtQ%3D%3D Occurrence Handle11676393

    Article  CAS  PubMed  Google Scholar 

  8. LM Liau KL Black RM Prins SN Sykes PL DiPatre TF Cloughesy DP Becker JM Bronstein (1999) ArticleTitleTreatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens J Neurosurg 90 1115–1124 Occurrence Handle1:STN:280:DyaK1M3nslOlsQ%3D%3D Occurrence Handle10350260

    CAS  PubMed  Google Scholar 

  9. R Yamanaka SA Zullo R Tanaka M Blaese KG Xanthopoulos (2001) ArticleTitleEnhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA J Neurosurg 94 474–481 Occurrence Handle1:CAS:528:DC%2BD3MXhvFKgtbY%3D Occurrence Handle11235953

    CAS  PubMed  Google Scholar 

  10. C Castelli WJ Storkus MJ Maeurer DM Martin EC Huang BN Pramanik TL Nagabhushan G Parmiani MT Lotze (1995) ArticleTitleMass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ T cells J Exp Med 181 363–368 Occurrence Handle10.1084/jem.181.1.363 Occurrence Handle1:CAS:528:DyaK2MXisl2rs70%3D Occurrence Handle7807017

    Article  CAS  PubMed  Google Scholar 

  11. AL Cox J Skipper Y Chen RA Henderson TL Darrow J Shabanowitz VH Engelhard DF Hunt CL Slingluff (1994) ArticleTitleIdentification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science 264 716–719 Occurrence Handle1:CAS:528:DyaK2cXltVKisbc%3D Occurrence Handle7513441

    CAS  PubMed  Google Scholar 

  12. GE Peoples PS Goedegeboure R Smith DC Linehan I Yoshino TJ Eberlein (1995) ArticleTitleBreast and ovarian-cancer specific cytotoxic T lymphocytes recognize the same HER/2neu-derived peptide Proc Natl Acad Sci USA 92 432–436 Occurrence Handle1:CAS:528:DyaK2MXjt12qsbo%3D Occurrence Handle7831305

    CAS  PubMed  Google Scholar 

  13. I Yoshino PS Goedegeboure GE Peoples AS Parikh JM DiMain HK Lyerly AF Gazdar TJ Eberlein (1994) ArticleTitleHER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer Cancer Res 54 3387–3390 Occurrence Handle1:CAS:528:DyaK2cXksFGntbc%3D Occurrence Handle7912166

    CAS  PubMed  Google Scholar 

  14. RM Steinman (1991) ArticleTitleThe dendritic cell system and its role in immunogenicity Ann Rev Immunol 9 271–296 Occurrence Handle10.1146/annurev.iy.09.040191.001415 Occurrence Handle1:CAS:528:DyaK3MXmt12kurc%3D

    Article  CAS  Google Scholar 

  15. JW Young K Inaba (1996) ArticleTitleDendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity J Exp Med 183 7–11 Occurrence Handle10.1084/jem.183.1.7 Occurrence Handle1:CAS:528:DyaK28XjsVCiug%3D%3D Occurrence Handle8551246

    Article  CAS  PubMed  Google Scholar 

  16. N Romani S Gruner D Brang E Kampgen A Lenz B Trockebacher GO Konwalinka P Fritsch RM Steinman G Schuler (1994) ArticleTitleProliferating dendritic cell progenitors in human blood J Exp Med 180 83–93 Occurrence Handle10.1084/jem.180.1.83 Occurrence Handle1:CAS:528:DyaK2cXkvVSrurw%3D Occurrence Handle8006603

    Article  CAS  PubMed  Google Scholar 

  17. JS Yu CJ Wheeler PM Zeltzer H Ying PK Lee F Incardona WH Yong RC Thompson MS Riedinger KL Black (2001) ArticleTitleDendritic cell immunotherapy for patients with glioblastoma multiforme and anaplastic astrocytoma Proc Am Assoc Cancer Res Abstr 42 274

    Google Scholar 

  18. R Yamanaka T Abe N Yajima N Tsuchiya J Homma T Kobayashi M Narita M Takahashi R Tanaka (2003) ArticleTitleVaccination of recurrent glioma patients with tumor-lysate pulsed dendritic cells elicits immune responses: results of clinical phase I/II trial Br J Cancer 89 1172–1179 Occurrence Handle10.1038/sj.bjc.6601268 Occurrence Handle1:CAS:528:DC%2BD3sXns1Cmu7k%3D Occurrence Handle14520441

    Article  CAS  PubMed  Google Scholar 

  19. CL Nastala HD Edington TG McKinney H Tahara MA Nalesnik MJ Brunda MK Gately SF Wolf RD Schreiber WJ Storkus (1994) ArticleTitleRecombinant IL-12 administration induces tumor regression in association with IFN- production J Immunol 153 1697–1706 Occurrence Handle1:CAS:528:DyaK2cXlslOgsbk%3D Occurrence Handle7913943

    CAS  PubMed  Google Scholar 

  20. F Ossendorp E Mengede M Camps R Filius CJ Melief (1998) ArticleTitleSpecific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors J Exp Med 187 693–702 Occurrence Handle10.1084/jem.187.5.693 Occurrence Handle1:CAS:528:DyaK1cXhs1antb0%3D Occurrence Handle9480979

    Article  CAS  PubMed  Google Scholar 

  21. MJ Micallef K Yoshida S Kawai T Hanaya K Kohno S Arai T Tanimoto K Torigoe M Fujii M Ikeda M Kurimoto (1997) ArticleTitleIn vivo antitumor effects of murine interferon–inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites Cancer Immunol Immunother 43 361–367 Occurrence Handle10.1007/s002620050345 Occurrence Handle1:CAS:528:DyaK2sXisVeitr4%3D Occurrence Handle9067408

    Article  CAS  PubMed  Google Scholar 

  22. R Yamanaka N Yajima T Abe N Tsuchiya J Homma M Narita M Takahashi R Tanaka (2003) ArticleTitleDendritic cell-based glioma immunotherapy (Review) Int J Oncol 23 5–15 Occurrence Handle1:CAS:528:DC%2BD3sXltFahsb4%3D Occurrence Handle12792771

    CAS  PubMed  Google Scholar 

  23. T Kobayashi R Yamanaka J Homma N Tsuchiya N Yajima S Yoshida R Tanaka (2003) ArticleTitleTumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma Cancer Immunol Immunother 52 632–637 Occurrence Handle10.1007/s00262-003-0408-5 Occurrence Handle1:CAS:528:DC%2BD3sXnsV2lu7k%3D Occurrence Handle12827308

    Article  CAS  PubMed  Google Scholar 

  24. M Onodera A Yachie DM Nelson H Welchlin RA Morgan RM Blaese (1997) ArticleTitleA simple and reliable method for screening retroviral producer clones without selectable markers Hum Gene Ther 8 1189–1194 Occurrence Handle1:CAS:528:DyaK2sXksF2ntrY%3D Occurrence Handle9215736

    CAS  PubMed  Google Scholar 

  25. A Anichini R Mortarini C Maccalli P Squarcina K Fleischhauer L Mascheroni G Parmiani (1996) ArticleTitleCytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma J Immunol 156 208–217 Occurrence Handle1:CAS:528:DyaK28XlsVOk Occurrence Handle8598464

    CAS  PubMed  Google Scholar 

  26. D Boczkowski SK Nair D Snyder E Gilboa (1996) ArticleTitleDendritic cells pulsed with RNA are potent antigen presenting in vitro and in vivo J Exp Med 184 465–472 Occurrence Handle10.1084/jem.184.2.465 Occurrence Handle1:CAS:528:DyaK28XltVCrs74%3D Occurrence Handle8760800

    Article  CAS  PubMed  Google Scholar 

  27. SK Nair D Snyder BT Rouse E Gilboa (1997) ArticleTitleRegression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts Int J Cancer 70 706–715 Occurrence Handle10.1002/(SICI)1097-0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7 Occurrence Handle1:STN:280:ByiB2M%2FpslQ%3D Occurrence Handle9096653

    Article  CAS  PubMed  Google Scholar 

  28. L Zitvogel JI Majordomo T Tjandrawan AB DeLeo MR Clarke MT Lotze WJ Storkus (1996) ArticleTitleTherapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87–97 Occurrence Handle10.1084/jem.183.1.87 Occurrence Handle1:CAS:528:DyaK28XjsVChtA%3D%3D Occurrence Handle8551248

    Article  CAS  PubMed  Google Scholar 

  29. S Romagnani (1992) ArticleTitleHuman TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology Int Arch Allergy Immunol 98 279–285 Occurrence Handle1:STN:280:ByyD2cvmtVY%3D Occurrence Handle1422257

    CAS  PubMed  Google Scholar 

  30. P Ghosh KL Komschlies M Cippitelli DL Longo J Subleski J Ye A Sica HA Young RH Wiltrout AC Ochoa (1995) ArticleTitleGradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth J Natl Cancer Inst 87 1478–1483 Occurrence Handle1:CAS:528:DyaK2MXpsVSms74%3D Occurrence Handle7674335

    CAS  PubMed  Google Scholar 

  31. M Kohyama K Saijyo M Hayasida T Yasugi M Kurimoto T Ohno (1998) ArticleTitleDirect activation of human CD8+ cytotoxic T lymphocytes by interleukin-18 Jpn J Cancer Res 89 1041–1046 Occurrence Handle1:CAS:528:DyaK1cXnt1Oju78%3D Occurrence Handle9849583

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryuya Yamanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamanaka, R., Honma, J., Tsuchiya, N. et al. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. J Neurooncol 72, 107–113 (2005). https://doi.org/10.1007/s11060-004-3550-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-3550-9

Keywords

Navigation